A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease

BACKGROUND: The safety and tolerability of regadenoson, a pharmacologic stress agent that is excreted primarily by the kidneys, were examined in subjects with chronic kidney disease (CKD). METHODS: This multicenter, double-blind, randomized, placebo-controlled study involved men and women, ≥18 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Ananthasubramaniam, Karthik, Weiss, Robert, McNutt, Bruce, Klauke, Barbara, Feaheny, Kathleen, Bukofzer, Stan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332362/
https://www.ncbi.nlm.nih.gov/pubmed/22259009
http://dx.doi.org/10.1007/s12350-011-9508-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332362/
https://www.ncbi.nlm.nih.gov/pubmed/22259009
http://dx.doi.org/10.1007/s12350-011-9508-3

Ejemplares similares